Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TPL's sworn claims of Felcyn and Johnson's questionable actions

43. The OCC refers in the Motion (at 9:10-18) to discussions that Mr. Leckrone had

with Ms. Felcyn and Mr. Johnson that are recalled rather differently by Mr. Leckrone. Over the

course of various conversations regarding PDS Management Committee operations in which

PTSC Director Felcyn has actively participated, the adverse impact of the pendency of TPL’s

bankruptcy on the MMP Licensing Program was often discussed. Mr. Leckrone urged the

importance of streamlining the process and avoiding distractions and issues which would

embolden infringers, damage the MMP Licensing Program, and consume precious resources,

including specifically the airing of the scores of various PTSC/TPL disputes which Director

Felcyn was urging be pursued, including whatever TPL claims might exist with respect to the

PDS bank transaction that may have been manipulated by PTSC Director Johnson, as well as

trading irregularities by Director Felcyn with respect to PTSC stock based on Insider information.

Share
New Message
Please login to post a reply